價格 | ¥39500 |
包裝 | 1mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-02 |
中文名稱:CLEC12A/MICL/CLL-1, Human, 重組蛋白 (His), FITC-Labeled | 英文名稱:CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His), FITC-Labeled |
品牌: TargetMol | 產(chǎn)地: 美國 |
保存條件: store at low temperature | Lyophilized powder: -20~-80°C for 1 year | Solution: -80°C for 6~12 month | Shipping with blue ice. | 產(chǎn)品類別: 抑制劑 |
貨號: TMPK-01005 |
名稱 | CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His), FITC-Labeled |
描述 | CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML. CLEC12A/MICL/CLL-1 Protein, Human, Recombinant (His), FITC-Labeled is expressed in HEK293 mammalian cells with N-His tag. The predicted molecular weight is 24.6 kDa and the accession number is Q5QGZ9-2. |
存儲條件 | store at low temperature | Lyophilized powder: -20~-80°C for 1 year | Solution: -80°C for 6~12 month | Shipping with blue ice. |
關鍵字 | CD-371 | PRO 34150 | CD 371 | DCAL 2 | CLL 1 | CD-303 | CLECSF-7 | CLECSF 11 | CLECSF-11 | CD 303 | CLECSF 7 | PRO-34150 |
成立日期 | 2013-04-18 (12年) | 注冊資本 | 589.8595萬人民幣 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 中間體,天然產(chǎn)物,生物化工,化學試劑,生物技術服務 | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
¥1950 |
VIP3年
|
上海滬震實業(yè)有限公司
|
2025-01-10 | |
詢價 |
VIP2年
|
北京百普賽斯生物科技股份有限公司
|
2024-12-16 | |
¥2100 |
VIP6年
|
上海澤葉生物科技有限公司
|
2025-01-10 |